减少临床就诊和抗逆转录病毒药物补充频率对HIV治疗结局影响的评估:系统综述与Meta分析
该系统综述与Meta分析检索2010年1月1日至2021年11月9日数据库,纳入10项研究(6项随机对照试验、3项观察性研究、1项同时提供观察性与随机对照数据),共15个干预组、33,599名≥16岁成人,来自8个撒哈拉以南非洲国家。与3个月临床咨询相比,6或12个月咨询在保留率上似乎无差异(RR 1.01,95%CI 0.97-1.04,p=0.682,8项研究,低确定性);6个月与3个月ART补充在保留率上似乎无差异(RR 1.01,95%CI 0.98-1.06,p=0.473,4项RCT,中等确定性);病毒抑制和死亡率证据不足。
要点
- 6或12个月临床咨询与3个月相比,保留率似乎无差异(RR 1.01,95%CI 0.97-1.04,低确定性)。
- 6个月与3个月ART补充相比,保留率似乎无差异(RR 1.01,95%CI 0.98-1.06,中等确定性)。
- 病毒抑制和死亡率证据不足,结论受干预组病毒载量结局漏检的显著影响。
核心结论
- 将临床咨询间隔延长至6或12个月、ART发药间隔延长至6个月,似乎与3个月间隔产生相似的保留率,但对病毒抑制和死亡率的结论较不稳健。
研究设计与样本
- 系统综述与Meta分析,检索2010年1月1日至2021年11月9日数据库,纳入比较减少(6至12个月)临床咨询或ART补充预约频率与3至6个月预约频率的随机对照试验和观察性研究。
- 共纳入10项研究(6项RCT、3项观察性研究、1项同时贡献观察性与RCT数据),代表15个干预组、33,599名≥16岁成人,来自8个撒哈拉以南非洲国家。
- 减少频率的临床咨询在卫生机构进行,减少频率的ART补充通过机构或社区药房及依从性小组提供。
- 使用Mantel-Haenszel方法生成保留率、病毒抑制和死亡率的合并风险比(RR)及95%置信区间,使用GRADE评估证据确定性。
主要发现
- 减少临床咨询频率(6或12个月)与3个月咨询相比,保留率似乎无差异(RR 1.01,95%CI 0.97-1.04,p=0.682,8项研究,低确定性),该发现在6个月和12个月咨询间隔及实施策略中一致。
- 病毒抑制的效应估计受干预组病毒载量结局漏检的显著影响,导致证据不确定。
- 死亡率证据不足(RR 1.12,95%CI 0.75-1.66,p=0.592,6项研究,极低确定性)。
- ART补充频率方面,6个月与3个月相比,保留率似乎无差异(RR 1.01,95%CI 0.98-1.06,p=0.473,4项RCT,中等确定性)。
- 6个月与3个月ART补充相比,死亡率似乎无差异(RR 1.45,95%CI 0.63-3.35,p=0.382,4项RCT,低确定性)。
临床怎么用
- 原文结论指出,将临床咨询间隔延长至6或12个月、ART发药间隔延长至6个月似乎与3个月间隔产生相似的保留率,但对病毒抑制和死亡率的结论较不稳健。
- 原文建议未来研究应确保完整的病毒载量结局确认,并探索效应机制、其他人群中的结局以及最佳提供和监测策略,以确保减少频率就诊在不同环境中的广泛适用性。
局限性
- 可用于比较12个月与6个月临床咨询的研究数量少。
- 比较实施策略的数据不足。
- 缺乏儿童、重点人群以及撒哈拉以南非洲以外低收入和中等收入国家的证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Global HIV treatment programs have sought to lengthen the interval between clinical encounters for people living with HIV (PLWH) who are established on antiretroviral treatment (ART) to reduce the burden of seeking care and to decongest health facilities. The overall effect of reduced visit frequency on HIV treatment outcomes is however unknown. We conducted a systematic review and meta-analysis to evaluate the effect of implementation strategies that reduce the frequency of clinical appointments and ART refills for PLWH established on ART. METHODS AND FINDINGS: We searched databases between 1 January 2010 and 9 November 2021 to identify randomized controlled trials (RCTs) and observational studies that compared reduced (6- to 12-monthly) clinical consultation or ART refill appointment frequency to 3- to 6-monthly appointments for patients established on ART. We assessed methodological quality and real-world relevance, and used Mantel-Haenszel methods to generate pooled risk ratios (RRs) with 95% confidence intervals for retention, viral suppression, and mortality. We evaluated heterogeneity quantitatively and qualitatively, and overall evidence certainty using GRADE. Searches yielded 3,955 records, resulting in 10 studies (6 RCTs, 3 observational studies, and 1 study contributing observational and RCT data) representing 15 intervention arms with 33,599 adults (≥16 years) in 8 sub-Saharan African countries. Reduced frequency clinical consultations occurred at health facilities, while reduced frequency ART refills were delivered through facility or community pharmacies and adherence groups. Studies were highly pragmatic, except for some study settings and resources used in RCTs. Among studies comparing reduced clinical consultation frequency (6- or 12-monthly) to 3-monthly consultations, there appeared to be no difference in retention (RR 1.01, 95% CI 0.97-1.04, p = 0.682, 8 studies, low certainty), and this finding was consistent across 6- and 12-monthly consultation intervals and delivery strategies. Viral suppression effect estimates were markedly influenced by under-ascertainment of viral load outcomes in intervention arms, resulting in inconclusive evidence. There was similarly insufficient evidence to draw conclusions on mortality (RR 1.12, 95% CI 0.75-1.66, p = 0.592, 6 studies, very low certainty). For ART refill frequency, there appeared to be little to no difference in retention (RR 1.01, 95% CI 0.98-1.06, p = 0.473, 4 RCTs, moderate certainty) or mortality (RR 1.45, 95% CI 0.63-3.35, p = 0.382, 4 RCTs, low certainty) between 6-monthly and 3-monthly visits. Similar to the analysis for clinical consultations, although viral suppression appeared to be better in 3-monthly arms, effect estimates were markedly influence by under-ascertainment of viral load outcomes in intervention arms, resulting in overall inclusive evidence. This systematic review was limited by the small number of studies available to compare 12- versus 6-monthly clinical consultations, insufficient data to compare implementation strategies, and lack of evidence for children, key populations, and low- and middle-income countries outside of sub-Saharan Africa. CONCLUSIONS: Based on this synthesis, extending clinical consultation intervals to 6 or 12 months and ART dispensing intervals to 6 months appears to result in similar retention to 3-month intervals, with less robust conclusions for viral suppression and mortality. Future research should ensure complete viral load outcome ascertainment, as well as explore mechanisms of effect, outcomes in other populations, and optimum delivery and monitoring strategies to ensure widespread applicability of reduced frequency visits across settings.
引用
- Le Tourneau N, Germann A, Thompson RR, et al. Evaluation of HIV treatment outcomes with reduced frequency of clinical encounters and antiretroviral treatment refills: A systematic review and meta-analysis. PLoS Med. 2022. PMID: 35316272. doi:10.1371/journal.pmed.1003959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。